Gossamer Bio, Inc. (GETTEX:4GB) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of pre-funded warrants and FDA approval warrants Announced: up to US$250M · US$0.1399 a share · Warrants at US$0.187 · Leerink Partners +1 Dealers: Leerink Partners (co-lead), Cantor (co-lead) Buyers: EcoR1 Capital; 683 Capital Partners, LP; RA Capital Management; Coastlands Capital; Samsara BioCapital; Rock Springs Capital Use of proceeds: Advance clinical development and potential commercialization of seralutinib in PAH and PH-ILD, general corporate purposes and working capital | Aug 21, 2026 |